Serological Response to COVID-19 Vaccination in Saudi Arabia: A Comparative Study of IgG and Neutralising Antibodies Across Vaccine Platforms

<b>Background</b>: In the Kingdom of Saudi Arabia, various COVID-19 vaccines were administered during the pandemic. However, region-specific real-word comparative data on their immunogenicity remain limited. This study aimed to assess the serological responses to Pfizer-BioNTech (BNT162b2), Moderna...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής

Κύριοι συγγραφείς:	Mariam M. AlEissa, Ahdab A. Alsaieedi, Reema Alduaiji, Fahad Almsned, Yousif AlDossary, Nada Saleh, Raghad A. AlQurashi, Esraa A. Hawsa, Muath b Ben Shaded, Amer M. Alshehri, Osamah T. Khojah, Eyad Y. Abu Sarhan, Hamad H. Alonazi, Walid A. Nouh, Khalid H. AlAnazi, Sami S. Almudrra, Khaled I. AlAbdulkareem, Abdullah AlJurayyan, Abdullah M. Asiri
Μορφή:	Artigo
Γλώσσα:	Inglês
Έκδοση:	MDPI AG 2025-10-01
Σειρά:	Vaccines
Θέματα:	SARS-CoV-2 COVID-19 vaccine immunogenicity neutralising antibodies Saudi Arabia mRNA vaccine
Διαθέσιμο Online:	https://www.mdpi.com/2076-393X/13/10/1042
Ετικέτες:	Προσθήκη ετικέτας Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!